Abstract
The death ligand TRAIL was discovered just over 10 years ago. In this
chapter, we summarize the most important findings on the biochemistry,
biology and potential therapeutic applicability of this promising novel cytokine.
We address a number of eminent questions. How does TRAIL
apoptosis signaling work and what is special about it? Why is this member
of the tumor necrosis factor family of cytokines so interesting for cancer
researchers and immunologists? What is the physiological role of the
TRAIL–TRAIL receptor system? We cannot provide full answers to all of
these questions; however, we intend to point out to the reader the most
important unsolved scientific questions regarding the biology of this
fascinating cytokine and its receptors.
| Original language | English |
|---|---|
| Title of host publication | Apoptosis and Cancer Therapy: From Cutting-edge Science to Novel Therapeutic Concepts Volume 1, 26 May 2008 |
| Pages | 31-92 |
| Number of pages | 62 |
| Volume | 1 |
| DOIs | |
| Publication status | Published - 2008 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Biochemistry
- Genetic aberrations
- Medicine (all)
- Physiological function
- Signaling
- Tumor tissue
Fingerprint
Dive into the research topics of 'Apoptosis and Cancer Therapy: From Cutting-edge Science to Novel Therapeutic Concepts'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver